Venous Stasis Dermatitis of the Lower Extremity
Conditions
Interventions
Electric Fire Needle Unit:Electric Fire Needle
Control Group:Halcinonide Cream
Sponsors
Beijing Aerospace General Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnosis of lower extremity venous stasis dermatitis (varicose eczema); 2. Disease staging follows the CEAP classification system, meeting the criteria for subclass C4a, where C4a is characterized by pigmentation or eczema, presenting as skin pigmentation or eczema, possibly accompanied by itching or skin thickening; 3. No use of antihistamines or other immunosuppressive drugs within the past 6 weeks; 4. Age between 40 and 80 years; 5. Voluntarily participates in the entire study, able to complete medical information forms and sign a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with any of the following conditions: bleeding disorders, coagulation disorders, immunodeficiency, or history of major bleeding; severe chronic diseases such as cardiovascular, cerebrovascular, liver, or kidney diseases; poorly controlled diabetic patients; acute infectious diseases or fever (body temperature =37.3?); patients with impaired consciousness or mental disorders. 2. Patients with a history of needle syncope or blood syncope, or those allergic to the drugs used in this study. 3. Patients in the pregnancy or lactation period, or those with a tendency to keloid formation. 4. Patients with severe psychological fear or unwillingness to undergo moxibustion therapy. 5. Patients who have participated in other clinical trials within the past 14 days. 6. Patients who have a history of systemic corticosteroid use, specific immunotherapy, or desensitization therapy within the past 3 months prior to enrollment. 7. Other situations deemed unsuitable for participation in clinical research by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy Index;Itching VAS score;EASI Scoring;VCSS Score;DLQI Score;Recurrence rate; | — |
Countries
China
Contacts
Public ContactHui Xin
Beijing Aerospace General Hospital
Outcome results
None listed